Landscapes / Companies
Tanabe Pharma Corporation not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 approved
2 in Phase 3
Drugs
4
in active trials · 39 in all
Trials
3 active
93 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
ADC Therapeutics S.A. |
Approved | Aug 2028Phase 1/2 trial completes | ||
| How it works | An antibody | ||||
| Next date | Aug 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Diffuse Large B-Cell Lymphoma | ||||
| Open drug page | |||||
— |
Approved in Japan | — | |||
| Also tested for | Systemic Sclerosis | ||||
| Open drug page | |||||
— |
TriGemX Bio |
Phase 3 | Feb 2027Phase 3 trial completes | ||
| Next date | Feb 2027 · Phase 3 trial completes | ||||
| Also tested for | Migraine, Acute Migraine | ||||
| Open drug page | |||||
— |
Phase 3 | Apr 2029Phase 3 trial completes | |||
| Next date | Apr 2029 · Phase 3 trial completes | ||||
| Also tested for | Pertussis, Diphtheria and 4 more | ||||
| Open drug page | |||||
About
- No active trial
- 35 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021